Stockholm-based BioTech startup Cellcolabs has raised €10.3 million in new funding to accelerate the industrial-scale production of mesenchymal stem cells (MSCs) and expand its global market presence. The round, led by Titian Capital through its Titian Life Sciences platform, brings Cellcolabs’ total funding to €31 million.
By Super Admin
|
October
28, 2025